Demos
TrialMind product demos
One-minute overviews for each team, and recorded walkthroughs of TrialMind on real studies.
One-minute overviews
What TrialMind does for each team, shown on real outputs.
Product overview
From a research question to an analysis plan, code that runs in your environment, and results traced back to the data.
Real-world evidence teams
A HER2-altered lung cancer cohort and sepsis treatment patterns, with the code behind every step.
Biometrics teams
Mapping to SDTM, generated code, Pinnacle 21 checks and a digital twin trial design.
Clinical operations teams
Eligibility criteria turned into screening rules, with the reason for every exclusion.
Competitive intelligence teams
A KRAS G12C trial landscape and conference coverage, with a link to every source.
Health economics and market access
A systematic literature review of GLP-1 drugs, from search to a cited draft.
Research institutions
A reproducible atrial fibrillation study on MIMIC, from analysis plan to patient flow diagram.
TrialPanorama
Semaglutide, tirzepatide and SURMOUNT-5: trials linked to drugs, results, adverse events and publications.
Biostatistics & Trial Design
View the solutionAnalysis dataset (ADaM) creation
CDISC Analysis Data Model (ADaM) tables derived from Study Data Tabulation Model (SDTM) domains, with the analysis plan recorded alongside the output.
Real-World Evidence
View the solutionFrom cohort definition to survival analysis
A recorded walkthrough of TrialMind on real data, from defining a cohort to a survival analysis.
Cohort extraction from real-world data
TrialMind writes the code to extract an eligible cohort from real-world data, then analyzes it.
Trial feasibility analysis
A feasibility question asked in plain language, answered with charts, without a separate data engineering step.
Lung cancer EGFR inhibitor feasibility and resistance
Feasibility and resistance analysis for EGFR tyrosine kinase inhibitor (TKI) therapies in non-small cell lung cancer (NSCLC), on real-world data.
KRAS G12C patient journeys
Treatment journeys of patients with KRAS G12C-mutant cancer, shown as summary dashboards and Sankey flow diagrams.
Health Economics & Market Access
View the solutionSystematic literature review
Search, screening, and extraction through to evidence synthesis, with decisions recorded.
Competitive & Portfolio Intelligence
View the solutionProbability of success prediction
Deep research across competing trials, literature, and drug evidence to assess regulatory success.
Clinical Development & Operations
View the solutionPatient-to-trial matching
Matching patients to actively recruiting trials against protocol eligibility criteria.
Book a demo on your own data
We can run TrialMind on a question from your own work in a live session.